BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results

  Zomedica Pharmaceuticals Corp. reported consolidated financial results for the second quarter ended June 30, 2018.

  August 9, 2018

   · 

  9 min read
• Business

  Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results

  Cyclacel Pharmaceuticals, Inc. reported financial results and business highlights for the second quarter 2018.

  August 9, 2018

   · 

  9 min read
• Business

  Kindred Biosciences Announces Second Quarter 2018 Financial Results

  Kindred Biosciences, Inc. announced financial results for the second quarter ended June 30, 2018 and provided updates on its programs.

  August 9, 2018

   · 

  16 min read
• Business

  Endologix Reports Second Quarter 2018 Financial Results

  Endologix, Inc. announced financial results for the second quarter ended June 30, 2018.

  August 9, 2018

   · 

  13 min read
• Business

  Magenta Therapeutics Reports Recent Operational Progress and Second Quarter 2018 Financial Results

  Transplanted first patient with MGTA-456 in Phase 2 study in inherited metabolic disorders

  August 9, 2018

   · 

  7 min read
• Business

  Spero Therapeutics Announces Second Quarter 2018 Financial Results and Pipeline Overview

  Pipeline continues to advance following recent positive data from SPR994 and Potentiator Platform; SPR994 Phase 3 initiation on-track to initiate around year-end

  August 9, 2018

   · 

  10 min read
• Business

  Cryoport Revenue Grows 59% for Second Quarter 2018; 73% in Biopharma

  Revenue from Approved CAR-T Therapies Continues to Ramp

  August 9, 2018

   · 

  19 min read
• Business

  SCYNEXIS Reports Second Quarter 2018 Financial Results and Provides Company Update

  Oral dose regimen of ibrexafungerp (formerly SCY-078) identified for Phase 3 VVC development; Phase 3 on track for initiation in the fourth quarter of 2018

  August 9, 2018

   · 

  15 min read
• Business

  Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial Results

  Cellect Biotechnology Ltd. provided a corporate update and announced financial results for the second quarter ended June 30, 2018.

  August 9, 2018

   · 

  24 min read
• Business

  IntelGenx Reports Second Quarter 2018 Financial Results

  IntelGenx Technologies Corp. reported financial results for the second quarter ended June 30, 2018.

  August 9, 2018

   · 

  6 min read